Literature DB >> 1631902

Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase.

P J Boor1, M B Trent, G A Lyles, M Tao, G A Ansari.   

Abstract

The capacity of the vascular enzyme, semicarbazide-sensitive amine oxidase (SSAO), to metabolize methylamine to the potentially toxic product, formaldehyde, was tested using rat aortic homogenates and purified porcine aortic SSAO. Formaldehyde production in incubations of enzyme source with methylamine (1 mM) was detected by high performance liquid chromatography and product was confirmed by desorption chemical ionization mass spectrometry (DCI-MS). Inhibitor studies using the specific SSAO inhibitor semicarbazide and the monoamine oxidase inhibitor pargyline indicate that SSAO is responsible for metabolism of methylamine to formaldehyde. These results suggest the possibility that elevated methylamine found in several pathologic states (such as uremia and diabetes mellitus), or generated from exogenous sources, could result in overproduction of formaldehyde in tissues with high SSAO activity, especially blood vessels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1631902     DOI: 10.1016/0300-483x(92)90067-o

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  22 in total

1.  Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy.

Authors:  P H Yu; C T Lai; D M Zuo
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.

Authors:  A G Jarnicki; H Schilter; G Liu; K Wheeldon; A-T Essilfie; J S Foot; T T Yow; W Jarolimek; P M Hansbro
Journal:  Br J Pharmacol       Date:  2016-10-12       Impact factor: 8.739

3.  A glutathione-dependent detoxification system is required for formaldehyde resistance and optimal survival of Neisseria meningitidis in biofilms.

Authors:  Nathan H Chen; Rafael M Couñago; Karrera Y Djoko; Michael P Jennings; Michael A Apicella; Bostjan Kobe; Alastair G McEwan
Journal:  Antioxid Redox Signal       Date:  2012-11-20       Impact factor: 8.401

4.  Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.

Authors:  P H Yu; D M Zuo
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

Review 5.  Semicarbazide-sensitive amine oxidase (SSAO) in the brain.

Authors:  Toshio Obata
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

6.  Formaldehyde promotes and inhibits the proliferation of cultured tumour and endothelial cells.

Authors:  E Tyihák; J Bocsi; F Timár; G Rácz; B Szende
Journal:  Cell Prolif       Date:  2001-06       Impact factor: 6.831

7.  Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.

Authors:  P H Yu
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

8.  Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.

Authors:  R Pirisino; C Ghelardini; G Banchelli; N Galeotti; L Raimondi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.

Authors:  Dmitriy Matveychuk; Emerson Nunes; Nasir Ullah; Carlos A Velázquez-Martinez; Erin M MacKenzie; Glen B Baker
Journal:  J Neural Transm (Vienna)       Date:  2013-02-08       Impact factor: 3.575

Review 10.  Hepatic consequences of vascular adhesion protein-1 expression.

Authors:  Chris J Weston; David H Adams
Journal:  J Neural Transm (Vienna)       Date:  2011-04-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.